Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study

被引:41
|
作者
Gordon, Nancy P. [1 ]
Green, Beverly B. [2 ]
机构
[1] Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA
[2] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA USA
关键词
CRC; Colorectal cancer screening; Fecal immunochemical test; Patient attitudes; OCCULT BLOOD-TESTS; PARTICIPATION; ADHERENCE; CARE;
D O I
10.1186/s12889-015-1908-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The one-sample fecal immunochemical test (FIT) is gaining popularity for colorectal cancer (CRC) screening of average-risk people. However, uptake and annual use remain suboptimal. Methods: In 2013, we mailed questionnaires to three groups of nonHispanic White, Black, and Latino Kaiser Permanente Northern California (KPNC) members ages 52-76 who received FIT kits in 2010-2012: Continuers did the FIT all 3 years; Converts in 2012, but not 2010 or 2011; and Nonusers in none of the 3 years. The questionnaires covered social influences, perceived CRC risk, reasons for using (Continuers, Converts) or avoiding using (Nonusers) the FIT, and recommendations for improving the kit. Results: Continuers (n = 607, response rate 67.5 %), Converts (n = 317, response rate 35.6 %), and Nonusers (n = 215, response rate 21.1 %) did not differ in perceived risk or family history of CRC, but Nonusers were less likely than Continuers and Converts to know someone who had polyps or CRC. Continuers, Converts, and Nonusers did not differ in social network encouragement of CRC screening, but did differ in believing that it was very important that they be screened (88.3 %, 68.4 %, 47.7 %) and that their medical team thought it very important that they be screened (88.6 %, 79.9 %, 53.9 %). Approximately half of Continuers and Converts completed the FIT to please their doctor. Converts were less likely than Continuers to use the FIT to "make sure they were OK" (53.7 % vs. 72.6 %) or "protect their health" (46.1 % vs. 76.4 %). Nearly half of Converts completed the FIT out of guilt. Approximately half of FIT kit users suggested adding a disposable glove, extra paper, and wider-mouth tube to the kit. Nonusers' reasons for not using the FIT included discomfort, disgust, or embarrassment (59.6 %); thinking it unnecessary (32.9 %); fatalism/fear (15.5 %); and thinking it too difficult to use (14.5 %), but < 10 % did not want CRC screening at all. Conclusions: Nonusers and irregular users of the FIT are less intrinsically motivated to get CRC screening than long-term users and more averse to preparing their stool sample. Changes to the FIT kit to address discomfort and difficulty factors might improve uptake and continued use.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
    Inge Stegeman
    Thomas R de Wijkerslooth
    Rosalie C Mallant-Hent
    Karin de Groot
    An K Stroobants
    Paul Fockens
    Marco Mundt
    Patrick MM Bossuyt
    Evelien Dekker
    [J]. BMC Gastroenterology, 12
  • [32] Analytical Sensitivity of a Quantitative Immunochemical Fecal Occult Blood Test (FIT) in Screening for Colorectal Cancer
    van Vuuren, Anneke
    van Roon, Aafke H.
    Francke, Jan
    Ouwendijk, Martine
    van Ballegooijen, Marjolein
    van Leerdam, Monique E.
    Kuipers, Ernst J.
    Boonstra, Joke G.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S188 - S188
  • [33] Improvement in screening for colorectal cancer associated with the use of immunochemical faecal occult blood test
    Launoy, G.
    [J]. PATHOLOGIE BIOLOGIE, 2009, 57 (06): : 488 - 492
  • [34] Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion A Randomized Clinical Trial
    Singal, Amit G.
    Gupta, Samir
    Skinner, Celette Sugg
    Ahn, Chul
    Santini, Noel O.
    Agrawal, Deepak
    Mayorga, Christian A.
    Murphy, Caitlin
    Tiro, Jasmin A.
    McCallister, Katharine
    Sanders, Joanne M.
    Bishop, Wendy Pechero
    Loewen, Adam C.
    Halm, Ethan A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (09): : 806 - 815
  • [35] False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use
    Domper Arnal, M. J.
    Garcia Mateo, S.
    Hermoso-Duran, S.
    Abad, D.
    Carrera-Lasfuentes, P.
    Velazquez-Campoy, A.
    Abian Franco, O.
    Lanas, A.
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (09) : 1861 - 1869
  • [36] False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use
    M. J. Domper Arnal
    S. García Mateo
    S. Hermoso-Durán
    D. Abad
    P. Carrera-Lasfuentes
    A. Velazquez-Campoy
    O. Abian Franco
    A. Lanas
    [J]. International Journal of Colorectal Disease, 2021, 36 : 1861 - 1869
  • [37] PROSPECTIVE COST-ACCOUNTING OF AN OUTREACH PROGRAM TO INCREASE FECAL IMMUNOCHEMICAL TEST (FIT)-BASED COLORECTAL CANCER (CRC) SCREENING AMONG UNDERINSURED PERSONS IN A RANDOMIZED TRIAL
    Ladabaum, Uri
    Mannalithara, Ajitha
    Rachocki, Carly
    Laleau, Victoria
    Garcia, Dianne
    Chen, Ellen
    Grimes, Barbara
    Vittinghoff, Eric
    Somsouk, Ma
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S75 - S75
  • [38] Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria
    Knapp, Gregory C.
    Alatise, Olusegun
    Olopade, Bolatito
    Samson, Marguerite
    Olasehinde, Olalekan
    Wuraola, Funmilola
    Odujoko, Oluwole O.
    Komolafe, Akinwunmi O.
    Arije, Olujide O.
    Castle, Philip E.
    Smith, J. Joshua
    Weiser, Martin R.
    Kingham, T. Peter
    [J]. PLOS ONE, 2021, 16 (01):
  • [39] Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
    Kim, Dae Ho
    Cha, Jae Myung
    Kwak, Min Seob
    Yoon, Jin Young
    Cho, Young-Hak
    Jeon, Jung Won
    Shin, Hyun Phil
    Joo, Kwang Ro
    Lee, Joung Il
    [J]. GUT AND LIVER, 2018, 12 (02) : 183 - 189
  • [40] Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening
    Schlichting, Jennifer A.
    Mengeling, Michelle A.
    Makki, Nader M.
    Malhotra, Ashish
    Halfdanarson, Thorvardur R.
    Klutts, J. Stacey
    Levy, Barcey T.
    Kaboli, Peter J.
    Charlton, Mary E.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2015, 28 (04) : 494 - 497